Synartro AB is a biotechnology company based in Uppsala, Sweden. The company specializes in the development of innovative solutions in the field of biopharmaceuticals and medical technologies. Its focus includes research and development aimed at addressing unmet medical needs through advanced biotechnological methods.
The company engages in various projects that leverage its expertise in protein engineering, drug formulation, and delivery systems. Synartro AB collaborates with academic institutions and other organizations to enhance its research capabilities and to facilitate the translation of scientific discoveries into practical applications. Through these partnerships, the company aims to contribute to advancements in healthcare and improve patient outcomes.